Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs SPARC-1613 (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Pharmacokinetics
- Sponsors Sun Pharma Advanced Research Company
- 02 Feb 2018 Status changed from not yet recruiting to recruiting.
- 24 May 2017 Planned initiation date changed from 15 May 2017 to 15 Jul 2017.
- 19 Apr 2017 New trial record